Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 58 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9073875

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  2. US 9073918

    Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  3. US 9067989

    Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  4. US 9066944

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  5. US 9067932

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  6. US 9062008

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  7. US 9062068

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  8. US 9062002

    Substituted pyridine derivatives as FabI inhibitors

    Aurigene Discovery Technologies Limited · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  9. US 9060971

    Combination pharmaceutical agents as inhibitors of HCV replication

    Enanta Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  10. US 9062075

    Tetrahydropyridine derivatives as FabI inhibitors

    Aurigene Discovery Technologies Limited · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  11. US 9062007

    Cyclic amide BACE-1 inhibitors having a benzamide substituent

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  12. US 9056891

    Synthetic peptide inhibitors of Wnt pathway

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  13. US 9051249

    Benzylamine derivatives as inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  14. US 9051319

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  15. US 9045443

    Nitric oxide donor neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  16. US 9045416

    WNT protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  17. US 9045559

    Method for screening inhibitors of interleukin-32 (IL-32)

    The Regents of the University of Colorado · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  18. US 9040522

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 26, 2015 · Expires May 21, 2035

    granted

  19. US 9040527

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted

  20. US 9034903

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 19, 2015 · Expires May 14, 2035

    granted

  21. US 9034311

    Pyridin-2(1 H)-one derivatives as JAK inhibitors

    Almirall, S.A. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  22. US 9029502

    Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 12, 2015 · Expires May 7, 2035

    granted

  23. US 9029344

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2015 · Expires May 7, 2035

    granted

  24. US 9029546

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2015 · Expires May 7, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.